Abstract
The debate on sharing clinical trial data has been dominated by individual patient data. Tammy Hoffmann and colleagues argue that, although patient level data are important, a focus on the other simpler elements of trial transparency should be the first priority
| Original language | English |
|---|---|
| Article number | j2782 |
| Journal | BMJ (Online) |
| Volume | 357 |
| DOIs | |
| Publication status | Published - 2017 |
Fingerprint
Dive into the research topics of 'Focus on sharing individual patient data distracts from other ways of improving trial transparency'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver